- Home
- HIHO vs SBFM Comparison
HIHO vs SBFM Comparison
Compare HIHO & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- SBFM
- Stock Information
- Founded
- HIHO 1990
- SBFM 2006
- Country
- HIHO Hong Kong
- SBFM United States
- Employees
- HIHO N/A
- SBFM N/A
- Industry
- HIHO Industrial Machinery/Components
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- SBFM Health Care
- Exchange
- HIHO Nasdaq
- SBFM Nasdaq
- Market Cap
- HIHO 8.2M
- SBFM 3.7M
- IPO Year
- HIHO 1996
- SBFM N/A
- Fundamental
- Price
- HIHO $1.96
- SBFM $3.06
- Analyst Decision
- HIHO
- SBFM
- Analyst Count
- HIHO 0
- SBFM 0
- Target Price
- HIHO N/A
- SBFM N/A
- AVG Volume (30 Days)
- HIHO 8.5K
- SBFM 121.6K
- Earning Date
- HIHO 10-10-2024
- SBFM 11-11-2024
- Dividend Yield
- HIHO 3.59%
- SBFM N/A
- EPS Growth
- HIHO N/A
- SBFM N/A
- EPS
- HIHO N/A
- SBFM N/A
- Revenue
- HIHO $7,648,000.00
- SBFM $30,481,982.00
- Revenue This Year
- HIHO N/A
- SBFM $86.70
- Revenue Next Year
- HIHO N/A
- SBFM $126.76
- P/E Ratio
- HIHO N/A
- SBFM N/A
- Revenue Growth
- HIHO 10.41
- SBFM 109.82
- 52 Week Low
- HIHO $1.70
- SBFM $2.42
- 52 Week High
- HIHO $2.36
- SBFM $660.00
- Technical
- Relative Strength Index (RSI)
- HIHO 59.79
- SBFM 49.32
- Support Level
- HIHO $1.92
- SBFM $2.85
- Resistance Level
- HIHO $2.00
- SBFM $3.05
- Average True Range (ATR)
- HIHO 0.07
- SBFM 0.15
- MACD
- HIHO 0.01
- SBFM 0.02
- Stochastic Oscillator
- HIHO 80.95
- SBFM 63.89
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.